A Phase II Study of OSI-774 (NSC-718781) in Patients With Locally Advanced or Metastatic Papillary Histology Renal Cell Cancer
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2013
At a glance
- Drugs Erlotinib (Primary)
- Indications Renal cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Aug 2005 New trial record.